Nivolumab in Combination with Irinotecan and 5-Fluorouracil (FOLFIRI) for Refractory Advanced Gastroesophageal Cancer
Year: 2020
Type: article
Source: Oncology
DOI: 10.1159/000505974
Authors: Jane E. Rogers, Lianchun Xiao, Allison Trail, Mariela Blum Murphy, Melissa Palmer, Jaffer A. Ajani
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3007794446
